Effectiveness of Dry Needling in Athletes With Chronic Hamstring Strain (NCT07569484) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effectiveness of Dry Needling in Athletes With Chronic Hamstring Strain
Egypt38 participantsStarted 2026-05-01
Plain-language summary
This study aims to evaluate the effectiveness of dry needling in reducing pain and improving functional outcomes in athletes with chronic hamstring strain. Chronic hamstring injuries are common among athletes and often lead to persistent pain, reduced performance, and limitations in daily and sports activities.
Dry needling is a therapeutic technique used to target myofascial trigger points and relieve muscle tension. This study will compare the effects of dry needling with conventional physiotherapy interventions to determine its role in managing chronic hamstring strain.
Participants will be athletes diagnosed with chronic hamstring strain. Outcomes will include pain intensity, muscle flexibility, and functional performance. The results of this study may help improve rehabilitation strategies and provide evidence for the use of dry needling in sports injuries.
Who can participate
Age range
18 Years – 35 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male football players aged 18 to 35 years.
* Diagnosed with chronic hamstring strain (CHS) confirmed by ultrasonography.
* Injury duration of more than 3 months.
* Classified as Grade I or Grade II hamstring strain.
* Currently participating in the competitive phase of football.
* Body Mass Index (BMI) between 21-25 kg/m².
Exclusion Criteria:
* Previous exposure to dry needling therapy.
* Presence of any other current lower limb injuries.
* Participation in another hamstring rehabilitation program.
* Active skin infection at or near the treatment area.
* Bleeding disorders or use of anticoagulant medications.
* Severe needle phobia or psychological intolerance to needling.
* Presence of neuromuscular disorders (e.g., muscular dystrophy or peripheral neuropathy).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Pain Intensity
Timeframe: Baseline (pre-intervention) and after 6 weeks of treatment